1st Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for CRO, LLC

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

LobbyistCovered position, as disclosed
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Legislative Director, former Sen. Pete Domenici
JAMES C WILTRAUT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2333 (118th)

Health Issues HCR

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

LobbyistCovered position, as disclosed
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Legislative Director, former Sen. Pete Domenici
JAMES C WILTRAUT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2333 (118th)

Budget/Appropriations BUD

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products.

LobbyistCovered position, as disclosed
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Legislative Director, former Sen. Pete Domenici
JAMES C WILTRAUT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products.

LobbyistCovered position, as disclosed
EDWARD HILD Chief of Staff, Sen. Lisa Murkowski; Legislative Director, former Sen. Pete Domenici
JAMES C WILTRAUT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.